MedTrace Logo

Study on the Level of Physical Activity in Patients Diagnosed With Breast Cancer in Spain

NCT07478939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 507

Last updated 2026-03-20

No results posted yet for this study

Summary

There is strong evidence demonstrating the benefits that physical activity (PA) provides for patients with breast cancer (BC), both in prevention and throughout various treatments and in survivorship. However, there is still very limited information available regarding the level or amount of PA undertaken by BC patients or survivors. On the other hand, although there are general recommendations for physical exercise- 150-300 minutes per week of moderate activity or 75-150 minutes per week of vigorous activity-the type of physical exercise that is best at each stage of the disease, as well as adherence and preferences for different exercise programs, has not been thoroughly studied.

Physical exercise is a healthy, easily implemented and low-cost intervention that ought to be much more widely adopted among the BC population.

Understanding all these factors will help us better assess the degree of implementation and compliance with exercise programs in our population of BC patients. This diagnosis will be the first step towards establishing new strategies to improve patients' PA levels and their adherence to exercise programs, ultimately ensuring that these changes become consolidated as new lifestyle habits that provide our patients with a preventive factor against relapses, as well as a better quality of life.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Patients access the questionnaire via a link that redirects them to the GEICAM intranet platform, where the questionnaire is hosted. The dissemination of the link is carried out through GEICAM's channels on social media, its website, and the newsletters to our members and patient associations. The dissemination of the link is conducted via GEICAM's channels on social media, GEICAM website, and newsletters for GEICAM members and patient associations. Additionally, information may be provided in paper format with the participation of our associates. The involvement of various national patient associations, with whom GEICAM has collaboration agreements, is expected to encourage the participation of as many patients as possible.

Sponsors & Collaborators

  • Spanish Breast Cancer Research Group

    lead OTHER

Principal Investigators

  • Study Director Study Director · Complejo Hospitalario Universitario A Coruña (CHUAC)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-08
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07478939 on ClinicalTrials.gov